MWNA
RCKT icon

Marshall Wace North America’s Rocket Pharmaceuticals RCKT Stock Holding History

Marshall Wace North America’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,578
Closed -$470K – 1730
2020
Q4 		$470K Buy
+8,578
New +$313K ﹤0.01% 1098
2020
Q3 		– Sell
-61,872
Closed -$1.3M – 1429
2020
Q2 		$1.3M Buy
61,872
+55,500
+871% +$1M 0.01% 693
2020
Q1 		$90K Buy
+6,372
New +$126K ﹤0.01% 1007
2019
Q3 		– Sell
-11,566
Closed -$174K – 1504
2019
Q2 		$174K Sell
11,566
-163,657
-93% -$2.86M ﹤0.01% 1050
2019
Q1 		$3.07M Buy
+175,223
New +$2.77M 0.02% 412

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return